Administration of Intravenous Medication to Adults and Children within the Community and Community Hospital. -Policy and Procedure

Size: px
Start display at page:

Download "Administration of Intravenous Medication to Adults and Children within the Community and Community Hospital. -Policy and Procedure"

Transcription

1 Administration of Intravenous Medication to Adults and Children within the Community and Community Hospital. -Policy and Procedure Description: The document prescribes how clinicians will administer medication via the intravenous route using a peripheral cannula. Key Words: Version: Adopted by: Intravenous peripheral cannula Five Quality Assurance Committee Date adopted: April 2012 Name of David Leeson originator/author: Name of Clinical Effectiveness Group responsible committee: Date issued for 2014 publication: Review date: January 2017 Expiry date: April 2017 Target audience: Clinical Staff Type of Policy (tick appropriate box) Clinical NHSLA Risk Management Standards if applicable: State Relevant CQC Standards: 1,2,4,8,9. Non Clinical - 1 -

2 CONTRIBUTION LIST Key individuals involved in developing the document Name Designation Karen Connor Original Policy Developer 2009 Jo Potts Original Policy Developer 2009 David Leeson Clinical Education Lead 2011 and 2014 update Julie Grant Clinical Education Lead 2011 Circulated to the following individuals for consultation Name Caroline Barclay Colin Bourne Corinne Hutton Debbie Leafe Jane Bulman Jo Bowley Joan Carter Joanne Charles Julie Neville Katie Willetts Lesley Tooley Lindsay Bowles Mary Marson Mel Hutchings Satheesh Kumar Vyv Wilkins Zoe Larosa Designation Nurse Consultant Advanced Practice - CCHS Clinical Trainer / Development Nurse MSOP Diana Nurse Bridge Park Plaza Clinical Education Lead CCHS Team Leader Unscheduled Care Team West Locality CCHS Unscheduled Care Team Sister - Loughborough Unscheduled Care Team Sister - Loughborough Lead Pharmacist CCHS Clinical Trainer / Development Nurse Senior Nurse Diana Service Clinical Education Lead CCHS Ward Manager Wd 1 St Lukes Hospital Unscheduled Care Team Sister Melton Infection Prevention and Control Nurse Medical Director - LPT Equality and Diversity Officer Ward Manager Feilding Palmer Hospital - 2 -

3 CONTENTS Section Contents Page - Title Page 1 - Contribution and Circulation List 2 - Contents 3 - Version Control 4 - Equality Statement, Due Regard, NHS Constitution 5 - Links to CQC standards 6 - Definitions 6 1 Introduction 7 2 Summary of Policy 7 3 Scope of Policy 8 4 Statutory Requirements 8 5 Roles and Responsibilities 8 6 Training and Education 10 7 Audit and Monitoring 11 8 References 12 APPENDICES 1 Preparation of bolus dose of drug 13 2 Administration of a peripheral intravenous bolus dose of 15 drug 3 Adding a drug to an infusion bag Administration of a drug added to an intravenous infusion 18 Information regarding Electronic Infusion Devices Formula and calculation for infusion without an Electronic Infusion device 5 Visual Infusion Phlebitis Score and Checklist 20 6 Competency Assessment Criteria Generic LCAT tool 22 LCAT Competency Assessment sign off sheet 7 Policy Training Requirements 24 8 Due Regard Screening 25 9 Monitoring and Audit

4 Version Control and Summary of Changes Version number Date Comments (description change and amendments) 1.0 October 2006 Adopted for LCR PCT 2.0 December April 2012 Updated and adopted for LPT Procedure tables created for ease of reading. Updated list of other relevant policies. Added links to Medical Devices for Electronic Infusion Devices. Updated Reference list. Added Visual Phlebitis Score and Cannula Chart 4.0 May 2014 Updated references, updated infection prevention and control measures, updated relevant reading. 5.0 February 2015 Removal of 10% rule and yellow labels on syringes for community hospitals. Updated VIPs scoring chart allows for clearer signatures and scoring. Updated to reflect Ulearn system. Updated references NMC code. All LPT Policies can be provided in large print or Braille formats, if requested, and an interpreting service is available to individuals of different nationalities who require them. Did you print this document yourself? Please be advised that the Trust discourages the retention of hard copies of policies and can only guarantee that the policy on the Trust website is the most up-to-date version. For further information contact: David Leeson Clinical Trainer / Practice Development Manager, Leicestershire Partnership NHS Trust Charnwood Mill, Sileby Rd, Barrow on Soar, Leics, LE12 8LR Tel: Mobile: / Office: david.leeson@leicspart.nhs.uk - 4 -

5 Equality Statement Leicestershire Partnership NHS Trust (LPT) aims to design and implement policy documents that meet the diverse needs of our service, population and workforce, ensuring that none are placed at a disadvantage over others. It takes into account the provisions of the Equality Act 2010 and advances equal opportunities for all. This document has been assessed to ensure that no one receives less favourable treatment on the protected characteristics of their age, disability, gender reassignment, marriage and civil partnership, pregnancy and maternity, race, religion or belief, sex (gender) or sexual orientation. In carrying out its functions, LPT must have due regard to the different needs of different protected equality groups in their area. This applies to all the activities for which LPT is responsible, including policy development, review and implementation. Due Regard The Trusts commitment to equality means that this policy has been screened in relation to paying due regard to the Public Sector Equality Duty as set out in the Equality Act 2010 to eliminate unlawful discrimination, harassment, victimisation; advance equality of opportunity and foster good relations. Please refer to Appendix 8 which provides a detailed overview of the due regard undertaken in support of this activity. NHS Constitution Core Principles The NHS will provide a universal service for all based on clinical need, not ability to pay. The NHS will provide a comprehensive range of services The following core principles apply to this policy. Shape its services around the needs and preferences of individual patients, their families and their carers Respond to different needs of different sectors of the population Work continuously to improve quality services and to minimise errors Support and value its staff Work together with others to ensure a seamless service for patients Help keep people healthy and work to reduce health inequalities Respect the confidentiality of individual patients and provide open access to information about services, treatment and performance - 5 -

6 Links to CQC standards TARGET/STANDARDS KEY PERFORMANCE INDICATOR Use of individualised care plans that clearly show user 1 involvement. Documented evidence of informed and ongoing consent to 2 treatment. 4 8 Evidenced by thorough assessment of clinical need and multidisciplinary involvement in decision making. In addition this policy draws on the latest of guidance regarding intravenous medication. Evidenced by the use of involvement of infection prevention and control team in drawing up this policy. Evidenced through the use of personalised prescribing and 9 safe administration of medication utilising the latest guidance. Definitions that apply to this Policy Aseptic Technique Bolus Cannula Extravasation Infiltration Non-Vesicant Phlebitis Thrombophlebitis Vesicant Mechanisms employed to reduce potential contamination. Concentrated medication and / or solution given rapidly over a short period of time. Hollow tube made of silastic, rubber plastic or metal used for accessing the body. Inadvertent infiltration of a vesicant solution or medication into the surrounding tissue. Inadvertent administration of a non-vesicant solution or medication into the surrounding tissue. Intravenous medication that generally does not cause tissue damage or sloughing if injected outside of a vein. Inflammation of a vein; may be accompanied by pain, erythema, oedema, streak formation and / or palpable cord; rated by a standard scale Visual infusion phlebitis score. Inflammation of the vein in conjunction with the formation of a blood clot (thrombus) Agent capable of causing injury when it escapes from the intended vascular pathway into surrounding tissue. Inadvertent infiltration of a vesicant solution or medication into the surrounding tissue

7 1. INTRODUCTION 1.1 The majority of medicines that are administered in the community setting are via the oral route. However, in certain clinical circumstances, administration of medicines via the intravenous route is preferred. Traditionally, this activity was carried out within acute hospitals as an in-patient or within the out-patient setting. 1.2 Our health, Our care, Our Say a new direction for community services (DOH 2006) highlighted the need for more care to take place nearer to the patient s home. This is reiterated in Care in Local Communities A New Vision and Model for District Nursing (DH 2013). As a result, there is more administration of intravenous medicines taking place in the community setting either within patients own homes or within community hospitals. 1.3 The organisation appreciates the importance of having such service provision in the community but also recognises the risks associated with such activities. 2. SUMMARY 2.1 This policy sets out the standards that must be adhered to by clinicians administering intravenous medicines within a community or community hospital setting in order to maintain patient safety. 2.2 This policy includes the administration of intravenous medication via o Peripheral IV cannula 2.3 This policy excludes the administration of intravenous medication via o Central Lines such as Skin Tunnelled catheters (Hickman Lines) or PICC lines (Peripherally Inserted Central Catheter) or Portacaths. The exclusions are dealt with specifically in separate relevant policies. 2.4 This policy excludes the administration of blood and blood products outside the community hospital environment. 2.5 There is specific guidance for the following procedures: Appendix 1. Preparation of a bolus dose of drug Appendix 2. Administration of a peripheral intravenous bolus dose of drug. Appendix 3. Adding a drug to an infusion bag. Appendix 4. Administration of a drug added to an intravenous infusion

8 3 SCOPE 3.1 This policy is applicable to nursing staff employed by the organisation and should be applied in conjunction with the following local and national policies and standards: o Administering Medication in the Community Setting Standard Operating Procedure LPT o Anaphylaxis LPT Policy o Aseptic Non Touch Technique LPT Policy o Hand Hygiene - LPT Policy o Management of Medical Devices and Equipment LPT Policy o Management of Sharps and exposure to Blood Born Virus LPT Policy o NPSA (2007) Promoting the Safer use of Injectable Medicines. London. NPSA. o Procedure Manual for the Care of Skin Tunnelled Catheters LPT Guidance o Royal College of Nursing (2010). Standards for Infusion Therapy, London. RCN. o Royal College of Nursing (2011). The Health and Safety (Sharp Instruments in Healthcare) Implementing Council Directive 2010/32/EU. Registered Nurses must always work within their professional NMC Code (2015) and adhere to the NMC Standards for Medicines Management (2008). 3.2 Training for the administration of blood and blood products within the designated community hospitals will be addressed separately however the training for administration of IV medicines MUST be completed prior to this mandatory training. 4. STATUTORY REQUIREMENTS 4.1 The Care Quality Commission standard 9b states that the provider has clear procedures followed in practice, monitored and reviewed for medicines handling that include administration of medicines 4.2 The National Health Service Litigation Authority states that the organisation has approved documents which describe the process for the administration of medication in all care environments. 4.3 Care Quality Commission requires standards 1, 2, 4, 8, and 9 to be met in relation to this activity. 5. ROLES AND RESPONSIBILITIES 5.1 Medical Staff / Non-Medical Prescribers To clinically assess the patient as required in order to manage and treat the clinical condition of the patient. Consider the 5 Rs of fluid replacement therapy. Resuscitation, Routine maintenance, Replacement, Redistribution and Reassessment in line with NICE guidance CG174. Initiate intravenous therapy when no other alternative is appropriate and ensure it is safe for drug to be given via the prescribed route

9 To correctly prescribe medication and where required authorise for the patient in order that treatment is facilitated in a timely fashion. Access information from the IV Monographs / BNF as required. Within Childrens services the CBNF or Monograph from the Childrens Hospital would be accessed. Ensure compatibility exists between the infusion fluid and medication, which is to be administered; ensuring the amount of medication prescribed is adequate until the patient is reviewed again. 5.2 Community Service Managers / Hospital Matrons To ensure that this policy is adhered to in the clinical setting and that there is a clear process for dissemination. To ensure that staff are released for clinical mandatory training requirements. To ensure that line mangers are clear in their roles and responsibilities in implementing this policy. To act in accordance with the organisations policy on the actions required of reporting untoward incidents. 5.3 Line Managers To ensure that their staff have had access to appropriate intravenous training and competency assessment and keep records of competence within the Nurses personal file. To ensure that staff attend the appropriate clinical essential to role training and updates. To ensure that staff have access to the correct equipment required to manage intravenous access safely. To ensure that their staff are working in line with this policy. 5.4 Staff undertaking intravenous administration Registered Nurses are responsible and accountable for their practice and should always work within their competence in accordance with The Code (NMC, 2015) and adhere to the Standards for Medicines Management (NMC, 2008). Registered Nurses must attend the required training run within house by the Clinical Education Team CHS or for Childrens Nurses that run by the Clinical Team Leads and also identify to their line manager any ongoing training needs. Registered Nurses must maintain their clinical skills within this area and must seek to refresh their knowledge and skills as required

10 Registered Nurses must access information from the IV Monographs / BNF as required. Within Childrens services the CBNF or Monographs from the Childrens Hospital would be accessed. Registered Nurses must be familiar with and demonstrate a working knowledge of policies and procedures. Registered Nurses must be adequately prepared and equipped to deal with an anaphylactic or untoward reaction. In community hospitals two Registered Healthcare Practitioners should check drugs to be given intravenously before administration, in accordance with the Trust Medicines Management Policy. Where applicable, calculations must be undertaken independently and the results compared by the two practioners. In the Community where Registered Nurses are administering the drug in the patient s home and have demonstrated the necessary knowledge and competence they may administer intravenous drugs without a second check. If involved with the administration of blood or blood products staff must have undertaken mandatory blood transfusion training (see section3.2). 5.5 Staff undertaking intravenous administrations using infusion pumps If the infusion requires to be given with the use of an electronic infusion device in line with monographs or information from the drug manufacturer, it is the Registered Nurses professional responsibility to ensure their competence by accessing training or by reading instruction manuals and declare such competence to the organisation prior to using the equipment. This is in line with the Management of Medical Devices and Equipment policy and The Code (NMC. 2015) 6. TRAINING / EDUCATION There is a need for training identified within this policy. In accordance with the classification of training outlined in the Trust Learning and Development Strategy this training has been identified as role development training. The Ulearn system will identify: who the training applies to, delivery method, the update frequency, learning outcomes and a list of available dates to access the training. A record of the staffs training will be recorded on the Ulearn system. 6.1 Practitioners must be Registered Nurses. Before accessing an intravenous line independently all staff must: Have completed the organisations competency based training and assessment programme to include Intravenous Therapy, Medicines Management, Anaphylaxis as well as Adult or Paediatric Basic Life Support

11 Have commenced a period of supervised practice within 4 months of attending the training. Provide evidence of assessment and competency signed by an appropriate assessor. Observation, supervised practice and assessment should ideally be carried out in the clinical area in which the practitioner normally works. It is possible to carry out assessment using a simulation dummy outside of the work place should the need arise. The dates of supervision and assessments must be documented in the LCAT record of supervision held by the practitioner, the assessor and supervisor must sign this document. The practitioner must keep a record of competency in their professional portfolio as well as having a copy lodged in their personal file held by the line manager. See LCAT assessment criteria form and information (Appendix 6) Staff employed from another trust must provide evidence of a completed training and assessment programme and completed competencies that should be current. A supportive competency assessment of the staff must be carried out to ensure that they have the required skills in line with this organisations policy. 6.2 Criteria for Supervisors For staff new to accessing intravenous ports and delivering medication via this route, supervision should be carried out by a specified member of staff with experience and competence in this skill. The specified member of staff must: Be a Registered nurse. Have a sound knowledge of the relevant policies and documents. 6.3 Criteria for Assessors Final assessment of Competency must be carried out using the LCAT (Leicester Clinical Assessment Tool) by an accredited LCAT assessor. A register of accredited assessors is held by the Clinical Education Leads. 7. AUDIT and MONITORING 7.1 Line managers will be expected to assess individual s ability prior to delegating the procedures associated with the access of intravenous ports and administration of intravenous medication. Nurses giving rise to cause of concern will be referred to the Clinical Education Lead in the relevant locality for further assessment and education in the procedures. Practitioners are expected to have completed the organisations competency based training and assessment programme to include Intravenous Therapy, Medicines Management, Anaphylaxis as well as Adult or Paediatric Basic Life Support. This will be monitored by the use of the Ulearn system and the use of appraisals by line managers

12 Regular audits looking at the administration of medicines intravenously will be carried out by the organisation in accordance with the audit calendar. The policy will be reviewed every 3 years in order to ensure clinical currency or before should evidence from relevant bodies emerge. The policy will be available electronically via intranet in all clinical areas. 8. REFERENCES: Department of Health (2006) Our Health, Our Care, Our Say a new direction for community services. London. TSO Department of Health (2013) Care in Local Communities A new Vision and Model for District Nursing. London. DH National Patient Safety Alert (2007) Alert 20 Promoting the Safer use of Injectable Medicines. London. NPSA. NICE (2013) Clinical Guideline Intravenous fluid therapy in adults in hospital. London. NICE Nursing and Midwifery Council (2008) Standards for Medicines Management, London. NMC Nursing and Midwifery Council (2015) The Code, London. NMC Nursing and Midwifery Council (2009) Record Keeping: Guidance for Nurses and Midwives, London. NMC Royal College of Nursing (2010) Standards for Infusion Therapy, London. RCN Royal College of Nursing (2011) Sharps Safety: Guidance to support implementation of the EU Directive 2010/32/EU on the prevention of sharps injuries in the health care sector. London. RCN

13 APPENDIX 1 INTRAVENOUS ADMINISTRATION PROCEDURE (PREPARATION OF BOLUS DOSE OF DRUG) ACTION 1 Discuss procedure with patient or parent / carer and obtain informed consent to the treatment. 2 Read all prescription and authorisation details and confirm they relate to the patient to be treated. Check that the medication has not inadvertently been given already. RATIONALE To check that the patient or parent / carer understands the procedure and treatment and gives his or her consent To ensure patient safety and that the prescription is detailed enough to safely administer from and to ensure that it is legal. 3 Check for patient allergies. To ensure patient safety and reduce the risk of an allergic and anaphylactic reaction 4 Ensure that the area in which the To reduce the risk of contamination and medication is to be prepared is as clean mistakes. and uncluttered and free of distraction as possible. 5 Assemble all equipment required. Check all expiry dates and that medication, diluents, and flushes are not damaged and have been stored correctly. 6 Check that the medication formulation, dose, infusion fluid and rate of administration correspond to the prescription and product information. 7 Calculate the volume of medicine solution needed to give the prescribed dose. If required check this with another registered nurse. To ensure patient safety and comply with NMC Standards for Medicines Management (2008) To ensure patient safety and comply with NMC Standards for Medicines Management (2008) To comply with NMC Standards for Medicines Management (2008) 8 Put on a clean single use disposable plastic apron. 9 Disinfect your work surface using 70% alcohol and 2% Chlohexidine swab. Wash hands with liquid soap and water and dry thoroughly. To reduce the risk of bacterial contamination during the procedure. 10 Open sterile field and unpack equipment onto it. Open diluents, flushes and medications ready to draw up. 11 Decontaminate hands using alcohol sanitiser and apply sterile latex free gloves. Allows for the preparation of equipment prior to the procedure without contamination. To reduce the risk of bacterial contamination during the procedure

14 12 Using latex free sterile gloves and ANTT (Aseptic Non Touch Technique) assemble needles and syringes. Prepare the injection by following the manufacturer s instructions. Draw up pre and post bolus flushes as required. 13 REMEMBER if piercing a rubber seal always cleanse with a swab of 70% alcohol and 2% Chlohexidine and leave to dry for 30 seconds. Using ANTT reduces the risk of bacterial contamination during the procedure. To ensure that bacterial contamination risk is reduced. 14 REMEMBER some medications require to be gently swirled to dissolve all of the powder and should not be allowed to bubble up. It may take several minutes to dissolve powders. Check monograph or reconstitution notes if unsure. 15 Always keep ampoules and any unused medicine until administration to the patient is complete and no untoward reactions have occurred. 16 Once solutions have been drawn up, remove the needle from the leur loc syringe and either fit a blind hub or a new sheathed needle to maintain asepsis. Once ampoules or vials have been disposed of they cannot be retrieved from sharps safes in the case of untoward reactions. Reduces the risk of accidental sharps injury and maintains asepsis of key parts. 17 Remove gloves and apron disposing of correctly according to policy

15 ADMINISTRATION OF A PERIPHERAL INTRAVENOUS BOLUS DOSE OF DRUG APPENDIX 2 ACTION 1 Before administering any drug check the following: Right patient, Right drug, Right dose, Right time, Right route. RATIONALE To comply with Standards for Medicines Management NMC (2008) 2 Obtain informed consent. To check that the patient understands the procedure and treatment and gives his or her consent 3 Check for allergies. To ensure patient safety and reduce the risk of an allergic and anaphylactic reaction 4 Check that an appropriate venous access device is in place this should include the use of an extension / octopus line and that the administration site is free of leakage, infection and inflammation. 5 Take all equipment to the patient. Use of an octopus / extension line enables ease of access and reduces the risk of vascular damage and device mobility. Leakage, inflammation and infection are possible contra indications to the use of the access device. RCN (2010) See Appendix 5 6 Wash and dry hands thoroughly Reduces the risk of bacterial contamination. 7 Apply fresh sterile non latex gloves and apron. 8 AT ALL TIMES TAKE CARE NOT TO TOUCH KEY PARTS - Clean the needleless valve (bionector) located at the end of the extension / octopus line thoroughly using Chlohexidine 2% and alcohol 70% swab and allow to dry for 30 seconds. 9 Ask the patient to promptly report any soreness at the access site or any discomfort at all. Recheck the access site and device for any signs of leakage, infection or inflammation. 10 Attach a 10ml leur loc syringe filled with sodium chloride 0.9% and flush with 5ml of the sodium chloride 0.9%. DO NOT FORCE. Reduces the risk of bacterial contamination. To prevent bacterial contamination during the procedure. Early detection of untoward reactions and prompt action will reduce further complications. To ensure patency of the device. 11 Disconnect the syringe. 12 Attach leur loc syringe containing drug as prescribed and inject over the appropriate amount of time. 13 Disconnect the syringe All drugs must only be injected over the prescribed rate and time as set out by IV monographs and manufacturer s instructions. Reduces the risk of speed shock

16 14 Attach a 10ml leur loc syringe filled with sodium chloride 0.9% and flush with 5ml of the sodium chloride 0.9% using a push / stop motion. To ensure the patient receives the full dose of the prescribed medication. Push / stop effectively cleanses the lumen of the device. 15 Clear away equipment and ensure the patient is comfortable and the line is secure. 16 Remove gloves and apron and dispose of appropriately then wash and dry hands thoroughly. 17 Make a detailed record of administration using appropriate documentation to include batch numbers and expiry dates. 18 Finally discard used ampoules / vials and sharps into the appropriate sharp safe. To comply with local policies and Record Keeping Guidance for Nurses and Midwives NMC (2009) Once ampoules or vials have been disposed of they cannot be retrieved from sharps safes in the case of untoward reactions

17 APPENDIX 3 INTRAVENOUS ADMINISTRATION PROCEDURE (ADDING A DRUG TO AN INFUSION BAG) ACTION RATIONALE 1 Prepare the medicine in the syringe using the method described in appendix 1. 2 Check the outer wrapper of the infusion solution is not damaged 3 Check the infusion solution is free of particles, haziness, discolouration and is intact. Remove the wrapper. 4 Using sterile gloves remove the tamper evident seal on the additive port according to manufacturer s instructions. Cleanse with 70% alcohol and 2% chlorhexidine swab and leave to dry for 30 seconds. 5 On a flat surface inject the medicine into the infusion through the centre of the injection point taking care to keep the tip of the needle away from the side of the infusion bag. 6 Once the drug has been added to the infusion bag remove the syringe and needle and gently invert the bag at least 5 times. 7 Check the appearance of the final infusion solution for haziness, discolouration and particles. 8 AT ALL TIMES TAKE CARE NOT TO TOUCH KEY PARTS On a flat surface attach administration / giving set to the infusion bag using the port provided. 9 Prime the administration / giving set slowly to reduce air gaps in the line. Ensure the end of the line is covered. 10 Community Hospital Nurses must fully complete the yellow infusion label and attach it to the bag. To ensure that asepsis of the contents have not been contaminated. Particles, haziness, discolouration would indicate contamination and must not be used. To reduce the risk of bacterial contamination. To prevent accidental piercing of the infusion bag. To ensure the medication is completely mixed within the infusion solution. Haziness, discolouration, and particles would indicate incompatibility or contamination and the infusion should not be used. Reduces the risk of bacterial contamination Reduces the risk of air embolus and prevents bacterial contamination. To ensure that all staff are aware of the addition of the drug to the infusion solution

18 ADMINISTRATION OF A DRUG ADDED TO AN INTRAVENOUS INFUSION APPENDIX 4 ACTION 1 Before administering any drug check the following: Right patient, Right drug, Right dose, Right time, Right route. RATIONALE To comply with local policies and NMC Standards for Medicines Management (2008). To keep the patient safe. 2 Obtain informed consent. To check that the patient understands the procedure and treatment and gives his or her consent. 3 Check for allergies. To ensure patient safety and reduce the risk of an allergic and anaphylactic reaction. 4 Check that an appropriate venous access device is in place which should include the use of an extension / octopus line and that the administration site is free of leakage, infection and inflammation. 5 Take all equipment to the patient. Use of an octopus / extension line enables ease of access and reduces the risk of vascular damage and device mobility. Leakage, inflammation and infection are possible contra indications to the use of the access device. RCN (2010).See appendix 5 6 Wash and dry hands thoroughly Reduces the risk of bacterial contamination. 7 Apply fresh sterile gloves. Reduces the risk of bacterial contamination. 8 AT ALL TIMES TAKE CARE NOT TO TOUCH KEY PARTS - Clean the needleless valve (bionector) located at the end of the extension / octopus line thoroughly using Chlohexidine 2% and alcohol 70% swab and allow to dry for 30 seconds. 9 Attach a 10ml leur loc syringe filled with sodium chloride 0.9% and flush with 5ml of the sodium chloride 0.9%. DO NOT FORCE. To prevent bacterial contamination during the procedure. To ensure patency of the device. 10 Disconnect the syringe. 11 Attach the administration / giving set and regulate and run the infusion as required 12 At this point the nurse may remove the gloves and apron dispose of appropriately. 13 Once infusion is complete stop the infusion. 14 Put on a fresh apron, decontaminate hands using hand sanitiser and apply fresh sterile gloves. All drugs must only be injected over the prescribed rate and time as set out by the prescription / authorisation or IV monographs and manufacturer s instructions. Reduces the risk of speed shock. Prevent accidental contamination of equipment or surroundings To reduce bacterial contamination

19 15 AT ALL TIMES TAKING CARE NOT TO TOUCH KEY PARTS Detach the administration / giving set from the access device. 16 Attach a 10ml leur loc syringe filled with sodium chloride 0.9% and flush with 5ml of the sodium chloride 0.9% using a push / stop motion. 17 Clear away equipment and ensure the patient is comfortable and the line is secure. 18 Discard used ampoules / vials and sharps into the appropriate sharp safe. 19 Ask the patient to promptly report any soreness at the access site or any discomfort at all. Recheck the access site and device for any signs of leakage, infection or inflammation. To prevent contamination of key parts To ensure the patient receives the full dose of the prescribed medication. Push / stop effectively cleanses the lumen of the device. To prevent cross infection Once ampoules or vials have been disposed of they cannot be retrieved from sharps safes in the case of untoward reactions Early detection of untoward reactions and prompt action will reduce further complications. 20 Make a detailed record of administration. To comply with local policies and Record Keeping Guidance for Nurses and Midwives NMC (2009) 21 Check that arrangements for monitoring fluid balance or clinical parameters have been made. Ensure that relevant documentation is made available for subsequent regular monitoring to take place. N.B. ELECTRONIC INFUSION DEVICES To keep patient safe and monitor for early complications. If the medication requires to be given with the use of an electronic infusion device in line with monographs or information from the drug manufacturer, it is the Registered Nurses professional responsibility to ensure their competence by accessing training or by reading instruction manuals and declare such competence to the organisation prior to using the equipment. This is in line with the Management of Medical Devices and equipment policy and The Code (NMC. 2008) N.B. WORKED EXAMPLE OF THE FORMULA FOR CALCULATING DRIP RATES IF NOT USING AN ELECTRONIC INFUSION DEVICE mls to be infused (500) X Drops per ml (20) = = 13.8 dpm (14) Hours to run (12) X Convert to min (60)

20 VISUAL INFUSION PHLEBITIS SCORE (VIPS) Taken from: Jackson A (1998) APPENDIX 5 IV Site appears healthy. No pain evident. No signs of phlebitis 0 OBSERVE CANNULA ONE of the following is evident: Slight pain near IV site Slight redness near IV site 1 Possible first signs of phlebitis OBSERVE CANNULA TWO of the following are evident: Pain at IV site Erythema Swelling ALL of the following signs are evident: Pain along the path of cannula Erythema Induration All of the following are evident and extensive: Pain along path of cannula Erythema Induration Palpable venous cord Pus All of the following are evident and extensive: All of the above PLUS Pyrexia Tissue damage Early stages of phlebitis 2 RESITE CANNULA Medium stage of phlebitis 3 RESITE CANNULA and CONSIDER TREATMENT Advanced stage of phlebitis or the start of thrombophlebitis RESITE CANNULA and INITIATE TREATMENT 4 COMPLETE INCIDENT FORM Advanced stage of thrombophlebitis 5 RESITE CANNULA and INITIATE TREATMENT COMPLETE INCIDENT FORM 20

21 VISUAL INFUSION PHLEBITIS SCORE AND CANNULA CHECKLIST (ANY SCORE GREATER THAN 0 REQUIRES AN ENTRY IN THE EVALUATION OF CARE) Patients Full Name: Date of Birth: NHS Number: Cannula No Date of cannulation Insertion of cannula Inserted by Insertion site Size / colour of cannula Manufacturer Batch no & expiry date VISUAL INFUSION PHLEBITIS SCORE Day 1 Night 1 Day 2 Night 2 Day 3 Night 3 Day 4 Night 4 Day 5 Night 5 Score Signature Score Signature Score Signature Score Signature Score Signature Remove the cannula unless the patient has poor venous access or clinician can justify leaving in situ. Removal of cannula Date of removal Removed by Swab Taken? Y / N Y / N Y / N Y / N Y / N Tip sent for C&S? Y / N Y / N Y / N Y / N Y / N Sterile dressing to site? Y / N Y / N Y / N Y / N Y / N 21

22 COMPETENCY ASSESSMENT CRITERIA GENERIC LCAT TOOL. Competency will be assessed by an authorised LCAT assessor using the LCAT assessment tool see next page - in conjunction with the procedure guides as per appendices 1-4 of this document. Prior to assessment candidates must: Attend the Intravenous Therapy theory session run throughout the organisation. Work through this policy. APPENDIX 6 Be aware of the areas of assessment as per the LCAT assessment tool below all five categories will be assessed. LCAT COMPETENCY ASSESSMENT SIGN OFF SHEET The LCAT sign off sheet is contained in the LCAT Record of Supervised Clinical Practice and is held by the practitioner. The LCAT record of Supervised Clinical Practice will be sent to the practitioner prior to attendance on the theory session in conjunction with a copy of this policy. It is recommended that copies of assessments are taken and held by the line manager and assessor for future reference.

23 Category and component competence 1.0 Communication and working with the patient and/or representative 1.1 Introduces self to patient and/or their family 1.2 Shares information about the procedure appropriately 1.3 Listens attentively 1.4 Answers questions honestly 1.5 Checks patient s understanding 1.6 Obtains valid and continuing consent 1.7 Works with the patient to maintain co-operation 1.8 Use of communication skills 1.9 Performs procedure in a compassionate and patient-centred manner 2.0 Safety 2.1 Checks patient s identity correctly 2.2 Checks/completes request and/or documentation correctly 2.3 Labels samples/printouts correctly 2.4 Applies procedure-specific safety measures correctly 2.5 Is aware of limitations of personal competence and role, and acts appropriately 2.6 Maximises own and others safety 2.7 Offers appropriate post-procedure care to the patient 3.0 Infection Prevention 3.1 Washes and/or decontaminates hands 3.2 Prepares patient s skin appropriately 3.3 Uses anti-infection barriers as required 3.4 Displays appropriate practice of aseptic technique 3.5 Disposes of waste appropriately 3.6 Optimises infection prevention within environmental limitations 4.0 Procedural Competence 4.1 Assesses the patient appropriately 4.2 Appropriately assesses the indications for and contra-indications to the proposed procedure 4.3 Plans the procedure with respect to patient factors 4.4 Prepares the patient appropriately 4.5 Selects and checks equipment, disposables, and consumables 4.6 Performs procedure fluently 4.7 Displays familiarity with equipment 4.8 Displays knowledge of the procedure 4.9 Uses assistance appropriately 4.10 Handles samples/ensures quality control of outputs correctly 4.11 Deals appropriately and sensitively with the evolving situation 4.12 Demonstrates respect for tissue 5.0 Team working 5.1 Displays understanding and respect for the roles of team members 5.2 Communicates effectively with the team 5.3 Leaves clinical area clean and tidy 5.4 Documents procedure correctly

24 APPENDIX 7 Policy Training Requirements The purpose of this template is to provide assurance that any training implications have been considered Training topic: Intravenous Access and Administration of Medication via Peripheral Cannulae Type of training: Role specific Division(s) to which the training is applicable: Adult Mental Health Services Community Health Services Families Young People Children Staff groups who require the training: Registered Nurses who are required as part of their job to access peripheral cannulae. Update requirement: Who is responsible for delivery of this training? Have resources been identified? Has a training plan been agreed? Where will completion of this training be recorded? Not fixed. Staff must work within NMC Standards. Clinical Education Team and Clinical Team Leads (Diana service) In place already Ongoing training programme In place already Trust learning management system and within apraisals as LCAT documents How is this training going to be monitored? Via Learning and Development team in conjunction with Clinical Education Team

25 APPENDIX 8 Section 1 Name of activity/proposal DUE REGARD SCREENING TOOL Administration of medication via peripheral cannulae Date Screening commenced 14 th May 2014 Directorate / Service carrying out the CCHS assessment Name and role of person undertaking David Leeson Clinical Education Lead this Due Regard (Equality Analysis) Give an overview of the aims, objectives and purpose of the proposal: AIMS: Update policy prescribing the standards to be adhered to when preparing and administering medication via a peripheral cannula OBJECTIVES: To ensure that any medication given via a peripheral cannula is given safely PURPOSE: To ensure both patient wellbeing and guard against staff errors.. Section 2 Protected Characteristic Could the proposal have a positive impact Yes or No (give details) Could the proposal have a negative impact Yes or No (give details) Age No No Disability No No Gender reassignment No No Marriage & Civil Partnership No No Pregnancy & Maternity No No Race No No Religion and Belief No No Sex No No Sexual Orientation No No Other equality groups? No No Section 3 Does this activity propose major changes in terms of scale or significance for LPT? For example, is there a clear indication that, although the proposal is minor it is likely to have a major affect for people from an equality group/s? Please tick appropriate box below. Yes High risk: Complete a full EIA starting click here to proceed to Part B No Low risk: Go to Section 4. Section 4 It this proposal is low risk please give evidence or justification for how you reached this decision: Implementation of this policy should not have a negative impact on any protected characteristics. It simply prescribes good clinical practice.

26 Process for Monitoring Compliance and Effectiveness APPENDIX 9 Minimum Requirements Process for Monitoring Frequency Responsible Group Ensure staff attend training to deliver the care as described in section 6 of this policy. Review by team managers of records of training that is recorded on the Ulearn system Quarterly Community Managers / Matrons Locality Governance Forum Ensure staff are competent to deliver the care as detailed in appendices 1-4 of this policy Review of staff LCAT assessments at appraisal by team managers. Annual Community Managers / Matrons Locality Governance forum Regular ongoing review of intravenous medication related incidents / complaints by Patient Safety and Experience Groups. The number of incidents/complaints reported via safeguard. Reported as required and as exception PSEG The use of the Visual Infusion Phlebitis Score and Cannula Checklist. Local audit process on the use of the Visual Infusion Phlebitis Score and Cannula Checklist to be carried out within teams. Annual CHS CAEG and Locality Governance Forum Where monitoring identifies any shortfall in compliance the group responsible for the Policy (as identified on the policy cov er) shall be responsible for developing and monitoring any action plans to ensure future compliance

Version: 5. Date Adopted: 17 April Date issued for publication: Review date: October Expiry date: 1 April 2021

Version: 5. Date Adopted: 17 April Date issued for publication: Review date: October Expiry date: 1 April 2021 The Policy and Procedure for the Administration of Intravenous Medication to Adults and Children within the Community and Community Hospital The document prescribes how clinicians will administer medication

More information

Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure

Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Quality and Standards Group Date

More information

DISTRICT NURSING and INTERMEDIATE CARE

DISTRICT NURSING and INTERMEDIATE CARE CLINICAL GUIDELINES DISTRICT NURSING and INTERMEDIATE CARE Schedule of guidelines attached: DNICT03 Community Procedure for the Administration of Intravenous Drugs via Bolus The guidelines scheduled above

More information

Central Venous Access Devices (CVAD) Procedures

Central Venous Access Devices (CVAD) Procedures SH CP 138 Central Venous Access Devices (CVAD) Procedures (e.g. Peripherally Inserted Central Catheter ( PICC lines) and Skin Tunnelled Central lines) Version:2 Summary: Keywords (minimum of 5): (To assist

More information

Intravenous Medication Administration via a Central Venous Line

Intravenous Medication Administration via a Central Venous Line Standard Operating Procedure 11 (SOP 11) Intravenous Medication Administration via a Central Venous Line Why we have a procedure? This procedure is to assist/ inform healthcare professionals on how to

More information

Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework

Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework Name: Location: Date commenced: Contents Competency: Page No: Page 1. Core: Introduction Demonstrate knowledge that

More information

Patient Self Administration of Intravenous (IV) Antibiotics at Home

Patient Self Administration of Intravenous (IV) Antibiotics at Home Trust Policy Document Ref. No: PP(16)319 Patient Self Administration of Intravenous (IV) Antibiotics at Home For use in: For use by: For use for: Document owner: Status: Clinical Areas Clinical Staff Patient

More information

Version: 2. Date adopted: 17 May publication: Review date: September Expiry date: March 2019

Version: 2. Date adopted: 17 May publication: Review date: September Expiry date: March 2019 Pest Control Policy This policy outlines the arrangements of management of pests on and within Trust properties Key words: Pest, Control Version: 2 Adopted by: Quality Assurance Committee Date adopted:

More information

Version: Date Adopted: 20 October Name of responsible Committee: Date issue for publication: Review Date: March 2018

Version: Date Adopted: 20 October Name of responsible Committee: Date issue for publication: Review Date: March 2018 Medical Gases Policy This policy sets out LPT s arrangements for the provision and management of Medical Gases used within the Trust. Key Words: Version: Adopted by: Medical, Gases V3 Quality Assurance

More information

STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES

STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES First Issued Issue Version One Purpose of Issue/ Description of Change To promote the safe administration

More information

Mid-line Vascular Access Device Policy (Adults) and Procedures/Guideline

Mid-line Vascular Access Device Policy (Adults) and Procedures/Guideline Mid-line Vascular Access Device Policy (Adults) and Procedures/Guideline October 2016 Document Profile Type i.e. Strategy, Policy, Procedure, Guideline, Protocol Title Category i.e. organisational, clinical,

More information

Derby Hospitals NHS Foundation Trust. Drug Assessment

Derby Hospitals NHS Foundation Trust. Drug Assessment Drug Assessment for Preparation and Administration of Oral, Enteral, Ophthalmic, Topical, PR, PV, Inhaled, Subcutaneous and Intramuscular Medicines to Patients (N.B. The preparation and administration

More information

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Obtain brief medical history including allergies & renal function. Informed verbal consent gained and documented and procedure and

More information

Administration of Intravenous Medication by Adults & Children s Services in the Community Setting and Adult Bed Based Units Policy

Administration of Intravenous Medication by Adults & Children s Services in the Community Setting and Adult Bed Based Units Policy High Value Health Care Administration of Intravenous Medication by Adults & Children s Services in the Community Setting and Adult Bed Based Units Policy (Reference No. CP53 8016) Version: Version 5, July

More information

ASEPTIC TECHNIQUE LEARNING PACKAGE

ASEPTIC TECHNIQUE LEARNING PACKAGE ASEPTIC TECHNIQUE LEARNING PACKAGE Staff Name:... Date:... Table of Contents What is Aseptic technique? 3 Core infection control components 3 Key parts 5 References 6 Aseptic technique questionnaire 7

More information

Intravenous Fluid Administration and Addition of Medicines to Intravenous Fluids (Drug Additives) (In-Patient Facilities) Interim Nursing Procedure

Intravenous Fluid Administration and Addition of Medicines to Intravenous Fluids (Drug Additives) (In-Patient Facilities) Interim Nursing Procedure This is an official Northern Trust policy and should not be edited in any way Intravenous Fluid Administration and Addition of Medicines to Intravenous Fluids (Drug Additives) (In-Patient Facilities) Interim

More information

Section G - Aseptic Technique. Version 5

Section G - Aseptic Technique. Version 5 Section G - Aseptic Technique Version 5 Important: This document can only be considered valid when viewed on the Trust s Intranet. If this document has been printed or saved to another location, you must

More information

Escorting Patients Policy

Escorting Patients Policy Escorting Patients Policy This Policy describes the process when escorting patients during visits out of the home or care environment Key Words: Escorting, community visits Version: 4 Adopted by: Quality

More information

POLICY FOR TAKING BLOOD CULTURES

POLICY FOR TAKING BLOOD CULTURES Sponsor: Reviewer(s): Dr Roberta Parnaby (Consultant Microbiologist) Dr Alicja Baczynska (F2 Microbiology) Dr Chris Gordon (Medical Director) Dr Roberta Parnaby Dr Matthew Dryden (Consultant Microbiologists)

More information

Community Intravenous Therapy Referral Standards

Community Intravenous Therapy Referral Standards pecialist harmacy ervice Medicines Use and afety Community Intravenous Therapy Referral tandards Background A multi-centred audit of prescribing and administration of community IV therapy across East and

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Injectable Medicines Policy Version No.: 4.3 Effective From: 24 March 2017 Expiry Date: 21 January 2019 Date Ratified: 11 January 2017 Ratified By:

More information

Administration of urinary catheter maintenance solution by a carer

Administration of urinary catheter maintenance solution by a carer Document level: Trustwide Code: CP71 Issue number: 1 Administration of urinary catheter maintenance solution by a carer Lead executive Director of Nursing Therapies Patient Partnership Authors details

More information

Document Details. notification of entry onto webpage

Document Details.  notification of entry onto webpage Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As

More information

Intravenous Therapy and Peripheral Cannulation Policy

Intravenous Therapy and Peripheral Cannulation Policy SH CP 137 Intravenous Therapy and Peripheral Cannulation Policy Version 3 Summary: Keywords: Target Audience: To enable patients on intravenous therapy to continue or complete treatment within the primary

More information

Hepatitis B Immunisation procedure SOP

Hepatitis B Immunisation procedure SOP Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical

More information

Risk Assessment Form HS 9 (1)

Risk Assessment Form HS 9 (1) s Full Name: Date of Birth: NHS Number 1. The fully implanted port system Sitimplant is not regularly used in the community and nursing staff may be unfamiliar with the recommended care of this system

More information

NUH Medicines Policy: Code of Practice. NUH Intravenous Drug Administration Policy

NUH Medicines Policy: Code of Practice. NUH Intravenous Drug Administration Policy NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST NUH Medicines Policy: Code of Practice Reference CL/MM/036 Approving Body Directors Group Date Approved 5 Implementation Date 5 Summary of n/a Changes from Previous

More information

This guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.

This guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin. CLINICAL GUIDELINE FOR THE SAFE ADMINISTRATION OF BOTULINUM NEURO TOIN FOR INJECTION within the PAIN SERVICE. Botox and eomin (trade names) 1. Aim/Purpose of this Guideline This guideline is for nursing

More information

Health & Social Services

Health & Social Services The States of Jersey Department for Health & Social Services AGREED PROCESS FOR COMMUNITY INTRAVENOUS THERAPY Date approved DOCUMENT PROFILE Document Registration Document Purpose Short Title Author Publication

More information

Chemotherapy Practice Competencies. To be used in conjunction with Teesside University module:

Chemotherapy Practice Competencies. To be used in conjunction with Teesside University module: Chemotherapy Practice Competencies To be used in conjunction with Teesside University module: AHH3088-N - Chemotherapy Enhancing Practice in Cancer Care School of Health & Social Care NAME. PLACE OF WORK

More information

FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING

FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING STANDARD OPERATING PROCEDURE FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING Issue History Issue Version One Purpose of Issue/Description of Change To promote safe and effective medicine administration

More information

TRUST DELIVERY GROUP: 22 AUGUST 2017 FOR: APPROVAL DISCUSSION INFORMATION. Acting Chief Nurse & Director of Patient Experience

TRUST DELIVERY GROUP: 22 AUGUST 2017 FOR: APPROVAL DISCUSSION INFORMATION. Acting Chief Nurse & Director of Patient Experience TRUST DELIVERY GROUP: 22 AUGUST 2017 FOR: APPROVAL DISCUSSION INFORMATION ITEM Lead: Designation: Jim Murray Acting Chief Nurse & Director of Patient Experience TRUST POLICY AND PROCEDURES FOR ASEPTIC

More information

ADMINISTRATION BY INJECTION POLICY INTRAVENOUS, INTRAMUSCULAR and SUBCUTANEOUS

ADMINISTRATION BY INJECTION POLICY INTRAVENOUS, INTRAMUSCULAR and SUBCUTANEOUS ADMINISTRATION BY INJECTION POLICY INTRAVENOUS, INTRAMUSCULAR and SUBCUTANEOUS This policy should be read in conjunction with the Syringe Driver Policy and the Medicines Policy Version: 6 Date of Issue:

More information

Central Venous Access Devices (CVADs) Hickman/Broviac and PICC Care Management Policy

Central Venous Access Devices (CVADs) Hickman/Broviac and PICC Care Management Policy Central Venous Access Devices (CVADs) Hickman/Broviac and PICC Care Management Policy (Note: See Separate Policy for Port-a-Cath Care and Management) DOCUMENT CONTROL: Version: v2 Ratified by: Quality

More information

ASEPTIC TECHNIQUE POLICY

ASEPTIC TECHNIQUE POLICY SECTION 3b ASEPTIC TECHNIQUE POLICY INFECTION CONTROL MANUAL Read in conjunction with: o Hand hygiene policy (also section 3) o Standard (Universal) Precautions policy (section 4) o Decontamination policy

More information

Directorate: Medical Due for Review: June Ope Owoso, Medicines Optimisation Pharmacist. Table of Contents

Directorate: Medical Due for Review: June Ope Owoso, Medicines Optimisation Pharmacist. Table of Contents Provider Community Services v 2.0 1923 Title: Injectable Medicines Policy for Registered Professionals Ref No: Version 2.0 Directorate: Medical Due for Review: June 2017 Responsible for review: Ratified

More information

Standard Precautions for Infection Control

Standard Precautions for Infection Control Standard Precautions for Infection Control Author(s) & Designation Lead Clinician if appropriate In consultation with To be read in association with Ratified by Suzanne Golding-Ellis, Head of Patient Safety

More information

Outpatient intravenous antibiotic therapy

Outpatient intravenous antibiotic therapy Oxford Centre for Respiratory Medicine Churchill Hospital Outpatient intravenous antibiotic therapy Patient Held Record Contents Page Introduction for patients 3 Introduction for the doctor or nurse 3

More information

Policy Checklist. Working Group: Administration of Infusion of Intravenous Fluids & Medicines in Neonates (Chairperson: Dr Hogan) YES

Policy Checklist. Working Group: Administration of Infusion of Intravenous Fluids & Medicines in Neonates (Chairperson: Dr Hogan) YES Policy Checklist Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Does this meet criteria of a Policy? Staff side consultation? Policy for the administration

More information

Sharps Policy Safe Use and Disposal

Sharps Policy Safe Use and Disposal Sharps Policy Safe Use and Disposal This procedural document supersedes: PAT/IC 8 v.6 Sharps Policy - Safe use and Disposal Did you print this document yourself? The Trust discourages the retention of

More information

Setting up and running a community IV therapy clinic

Setting up and running a community IV therapy clinic Setting up and running a community IV therapy clinic Moving care to the community has been a UK-wide health and social care priority for more than a decade (Royal College of Nursing [RCN], 2013). With

More information

SOP Venesection Registered Nurses

SOP Venesection Registered Nurses HAEM / ONC WARD & DAY UNIT STANDARD OPERATING PROCEDURE SOP Venesection Registered Nurses Document Code Version Number 1 Issue Number 1 Date of Issue 07/03/2014 Review Interval 2 years Author (original

More information

Department Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual

Department Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual Department Policy Code: D: MM-5615 Entity: Fairview Pharmacy Services Department: Fairview Home Infusion Manual: Policy and Procedure Manual Category: Home Infusion Subject: Chemotherapy Purpose: Ensure

More information

AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and Examination Policy

AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and Examination Policy AMPH-PGN-10 Practice Guidance Note Intramuscular Injection (IMI) V01 Date Issued Planned Review PGN No: Issue 1 Sep 2017 Sep 2020 AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and

More information

Developed in response to: Best Practice Health and Social Act 2008 CQC Fundamental Standards: 12

Developed in response to: Best Practice Health and Social Act 2008 CQC Fundamental Standards: 12 ASEPTIC TECHNIQUE AND ASEPTIC NON- TOUCH TECHNIQUE Clinical Guideline Register No: 08038 Status : Public Developed in response to: Best Practice Health and Social Act 2008 CQC Fundamental Standards: 12

More information

1. Infection Control, Centers for Disease Control and Prevention (CDC). (2002). Guideline for hand hygiene in health-care settings

1. Infection Control, Centers for Disease Control and Prevention (CDC). (2002). Guideline for hand hygiene in health-care settings HOSPITAL CORPSMAN SKILLS BASIC (HMSB) MAY 8 Checklist (PCL) Clinical Skill: Intravenous Therapy Circle One: Initial Evaluation Re-Evaluation Command: A. INTRODUCTION Upon successful completion of this

More information

CLINICAL PROCEDURE CONSERVATIVE SHARP DEBRIDEMENT FOR COMMUNITY PODIATRISTS

CLINICAL PROCEDURE CONSERVATIVE SHARP DEBRIDEMENT FOR COMMUNITY PODIATRISTS CLINICAL PROCEDURE CONSERVATIVE SHARP DEBRIDEMENT FOR COMMUNITY PODIATRISTS Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 1 To provide Podiatrists with the fundamental

More information

Medical Needs Policy. Policy Date: March 2017

Medical Needs Policy. Policy Date: March 2017 Medical Needs Policy Policy Date: March 2017 Renewal Date: March 2017 Equality Statement This policy takes into account the provisions of the Equality Act 2010 and advances equal opportunities for all.

More information

Blood Administration for Community Patients Policy

Blood Administration for Community Patients Policy Blood Administration for Community Patients Policy Policy Title: Blood Administration for Community Patients Policy Policy Reference Number: PrimCare08/15 Implementation Date: Review Date: July 2010 Responsible

More information

Recommendations from National Patient Safety Agency alerts that remain relevant to the Never Events list 2018

Recommendations from National Patient Safety Agency alerts that remain relevant to the Never Events list 2018 Recommendations from National Patient Safety Agency alerts that remain relevant to the Never Events list 2018 January 2018 We support providers to give patients safe, high quality, compassionate care within

More information

Wyoming STATE BOARD OF NURSING

Wyoming STATE BOARD OF NURSING David D. Freudenthal Governor Wyoming STATE BOARD OF NURSING Mary Kay Goetter, PhD, RNC, NEA-BC Executive Director 1810 Pioneer Avenue Cheyenne, Wyoming 82002 Phone: 307-777-7601 FAX: 307-777-3519 http://nursing.state.wy.us

More information

Nursing Guidelines on the Administration of Coagulation Factor Concentrate

Nursing Guidelines on the Administration of Coagulation Factor Concentrate Nursing Guidelines on the Administration of Coagulation Factor Concentrate Version Number 2 Date of Issue 2 nd April 2014 Reference Number Review Interval Approved By Name: Fionnuala O Neill Title: Chairperson

More information

PROCEDURE FOR TAKING A WOUND SWAB

PROCEDURE FOR TAKING A WOUND SWAB CLINICAL PROCEDURE PROCEDURE FOR TAKING A WOUND SWAB Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 2 To provide a standardised process of the fundamental principles

More information

The School Of Nursing And Midwifery. CLINICAL SKILLS PASSPORT

The School Of Nursing And Midwifery. CLINICAL SKILLS PASSPORT The School Of Nursing And Midwifery. BMedSci Nursing (Adult) CLINICAL SKILLS PASSPORT Student Details NAME: COHORT: I understand that this booklet may be reviewed by my mentor, the programme leader, my

More information

NON-MEDICAL PRESCRIBING POLICY

NON-MEDICAL PRESCRIBING POLICY NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August

More information

PROCEDURE FOR CHECKING THE WATER IN BALLOON RETAINED GASTROSTOMY TUBE / LOW PROFILE DEVICES FOR BOTH ADULTS AND CHILDREN

PROCEDURE FOR CHECKING THE WATER IN BALLOON RETAINED GASTROSTOMY TUBE / LOW PROFILE DEVICES FOR BOTH ADULTS AND CHILDREN PROCEDURE FOR CHECKING THE WATER IN BALLOON RETAINED GASTROSTOMY TUBE / LOW PROFILE DEVICES FOR BOTH ADULTS AND CHILDREN First Issued Issue Version Purpose of Issue/Description of Change Planned Review

More information

POLICY FOR ASEPTIC TECHNIQUE AND ASEPTIC NON TOUCH TECHNIQUE

POLICY FOR ASEPTIC TECHNIQUE AND ASEPTIC NON TOUCH TECHNIQUE POLICY FOR ASEPTIC TECHNIQUE AND ASEPTIC NON TOUCH TECHNIQUE Please be aware that this printed version of the Policy may NOT be the latest version. Staff are reminded that they should always refer to the

More information

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Aseptic Technique Policy

Aseptic Technique Policy Post holder responsible for Policy Author of Policy Division/ Department responsible for Procedural Document Contact details Judy Potter, Lead Nurse/Director Infection Prevention& Control Judy Potter,

More information

Medicine Management Standard Operating Procedures (SOP) September 2015

Medicine Management Standard Operating Procedures (SOP) September 2015 Medicine Management Standard Operating Procedures (SOP) September 2015 Responsible Committee: Clinical Governance Committee Date Effective: September 2015 Supersedes: December 2014 Next Review Done: December

More information

NHSGGC CME T34 SYRINGE PUMP COMPETENCY FRAMEWORK for PALLIATIVE CARE in ADULTS PRIMARY CARE

NHSGGC CME T34 SYRINGE PUMP COMPETENCY FRAMEWORK for PALLIATIVE CARE in ADULTS PRIMARY CARE NHSGGC CME T34 SYRINGE PUMP COMPETENCY FRAMEWORK for PALLIATIVE CARE in ADULTS PRIMARY CARE In compliance with professional guidelines, NMC: The Code: standards of conduct, performance and ethics for nurses

More information

FREEDOM OF INFORMATION ACT

FREEDOM OF INFORMATION ACT FOI REF: 18/298 6 th June 2018 FREEDOM OF INFORMATION ACT I am responding to your request for information under the Freedom of Information Act. The answers to your specific questions are as follows: Please

More information

NURSING GUIDELINES ON TAKING BLOOD CULTURES FROM PERIPHERAL OR CENTRAL VENOUS ACCESS DEVICE

NURSING GUIDELINES ON TAKING BLOOD CULTURES FROM PERIPHERAL OR CENTRAL VENOUS ACCESS DEVICE NURSING GUIDELINES ON TAKING BLOOD CULTURES FROM PERIPHERAL OR CENTRAL VENOUS ACCESS DEVICE Version Number V22 Date of Issue June 2017 Reference Number Review Interval Approved By Name: Fionnuala O Neill

More information

Best Practice Guidelines BPG 5 Catheter Care

Best Practice Guidelines BPG 5 Catheter Care Best Practice Guidelines BPG 5 Catheter Care BGP 5 1 DOCUMENT STATUS: Reviewed DATE ISSUED: March 2014 DATE TO BE REVIEWED: 13.10.17 AMENDMENT HISTORY VERSION DATE AMENDMENT HISTORY V1 March 2014 New Guideline

More information

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline 1.1. Guidelines for the use of rectus sheath catheters for the management of pain following laparotomy

More information

NBCP PO C Administration of injections

NBCP PO C Administration of injections POLICY CATEGORY: POLICY FOCUS: POLICY NAME: Administration of injections policy (EN) LAST UPDATED: February 2014 MOTION NUMBER: C-14-02-08 OTHER: GM-PP-I-03 (Supplement to administration of injections

More information

Undertake care for individuals with urinary catheters

Undertake care for individuals with urinary catheters About this Unit This standard covers undertaking care of individuals with urinary catheters. It is applicable in any care setting where an individual has a urinary catheter in position. This standard involves

More information

Version: 5 Date Issued: 24 October 2017 Review Date: 24 October 2020 Document Type: Policy. Sharps Safety Policy Quick Reference Guide

Version: 5 Date Issued: 24 October 2017 Review Date: 24 October 2020 Document Type: Policy. Sharps Safety Policy Quick Reference Guide Sharps Safety Policy Version: 5 Date Issued: 24 October 2017 Review Date: 24 October 2020 Document Type: Policy Contents Page Paragraph Executive Summary 2 1 Introduction 3 2 Scope 3 3 Purpose 3-4 4 Definitions

More information

Giving Intravenous (IV) Nutrition Through a Central Line with a CADD Pump

Giving Intravenous (IV) Nutrition Through a Central Line with a CADD Pump Home Care Services Giving Intravenous (IV) Nutrition Through a Central Line with a CADD Pump Receiving medicine and supplies When you receive a shipment, make sure you have the correct medicine and supplies.

More information

NATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT. Safer Use of Injectable Medicines In Near-Patient Areas

NATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT. Safer Use of Injectable Medicines In Near-Patient Areas NATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT Safer Use of Injectable Medicines In Near-Patient Areas Wide Stake Holder Consultation January March 2006 The NPSA is undertaking a wide stake

More information

Expiry Date 28/08/2015 Withdrawn Date

Expiry Date 28/08/2015 Withdrawn Date Policy No: MM03 Version: 1.0 Name of Policy: Administration of Medicines Policy Effective From: 03/10/2012 Date Ratified 29/08/2012 Ratified Medicines Governance Group Review Date 01/08/2014 Sponsor Medical

More information

North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2)

North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2) North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2) No. Objective Actions Lead Date of 1 Leadership throughout Accountability

More information

Moving and Handling Policy

Moving and Handling Policy Moving and Handling Policy Ratified Quality, Patient Safety and Risk / 16/04/2014 / 2014-40 Status Ratified Issued April 2014 Approved By Quality, Patient Safety and Risk Committee Consultation Quality,

More information

Blood Culture Policy

Blood Culture Policy Policy No: IC27 Version: 5.0 Name of Policy: Blood Culture Policy Effective From: 21/09/2015 Date Ratified 15/09/2015 Ratified Infection Prevention and Control Committee Review Date 01/09/2017 Sponsor

More information

Administration of Medication IV Push to Neonatal/Paediatric & Adult Patients Self-Learning Package

Administration of Medication IV Push to Neonatal/Paediatric & Adult Patients Self-Learning Package Administration of Medication IV Push to Neonatal/Paediatric & Adult Patients Self-Learning Package Prepared by Cheryl Owen, CPL Medicine, Rose Owen CPL NICU/SCN; Jan. 2008 Revised by Rose Owen CPL NICU/SCN;

More information

Linen Services Policy

Linen Services Policy Policy No: IC10 Version: 6.0 Name of Policy: Linen Services Policy Effective From: 18/08/2015 Date Ratified 15/07/2015 Ratified Infection Prevention and Control Committee Review Date 01/07/2017 Sponsor

More information

Managing medicines in care homes

Managing medicines in care homes Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience

More information

PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS

PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS STANDARD OPERATING PROCEDURE PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS Issue History Issue Version one Purpose of Issue/Description of Change To facilitate patients

More information

M-fhUb~a.2. ~ Feidhmeannacht na Seirbhise Siainte Hea1Ul Service Executive

M-fhUb~a.2. ~ Feidhmeannacht na Seirbhise Siainte Hea1Ul Service Executive Feidhmeannacht na Seirbhise Siainte Hea1Ul Service Executive TITLE: Cannula Care Guideline for Nurses and Midwives at Mid-Western Regional Hospital, (MWRH),, Regional Orthopaedic Hospital, Croom and Regional

More information

CENTRAL IOWA HEALTHCARE Marshalltown, Iowa

CENTRAL IOWA HEALTHCARE Marshalltown, Iowa CENTRAL IOWA HEALTHCARE Marshalltown, Iowa CARE OF PATIENT POLICY & PROCEDURES Policy Number: 4.37 Subject: Implanted Venous Access Device (Infus-A-Port), Nursing Management Of (Indwelling Vascular Access

More information

Guidance and Procedures for Pre-filling Insulin Syringes

Guidance and Procedures for Pre-filling Insulin Syringes Guidance and Procedures for Pre-filling Insulin Syringes 2017-2019 Reference No: G_CS_89 Version 1 Ratified by: LCHS Trust Board Date ratified: 14 th November 2017 Name of originator / author: Diabetes

More information

Contract of Employment

Contract of Employment JOB DESCRIPTION AND PERSON SPECIFICATION FOR Deputy Sister / Deputy Charge Nurse AGENDA FOR CHANGE BAND Band 6 HOURS AND DURATION As specified in the job advertisement and the Contract of Employment AGENDA

More information

21 st Century Health Care Consultants

21 st Century Health Care Consultants 21 st Century Health Care Consultants Presents 1 Investing in your Infusion Specialty Program Presented by: Rhonda Surgnier RN Becky Tolson RN David Kachel CRNI INFUSION THERAPY OBJECTIVES 2 At the completion

More information

Management of Reported Medication Errors Policy

Management of Reported Medication Errors Policy Management of Reported Medication Errors Policy Approved By: Policy & Guideline Committee Date of Original 6 October 2008 Approval: Trust Reference: B45/2008 Version: 4 Supersedes: 3 February 2015 Trust

More information

Venepuncture, obtaining blood cultures and managing blood samples

Venepuncture, obtaining blood cultures and managing blood samples Venepuncture, obtaining blood cultures and managing blood samples Aims To ensure that students are able to demonstrate the safe and correct technique for venepuncture, obtaining blood cultures and managing

More information

Home therapy with Immunoglobulin

Home therapy with Immunoglobulin Home therapy with Immunoglobulin Turnberg Building Immunology Department 0161 206 5576 All Rights Reserved 2017. Document for issue as handout. You have been diagnosed with antibody deficiency and you

More information

CENTRAL VENOUS ACCESS DEVICE POLICY

CENTRAL VENOUS ACCESS DEVICE POLICY CENTRAL VENOUS ACCESS DEVICE POLICY Version: 1 Date of Issue: April 2018 Review Date: April 2021 Applies to: All clinical staff who care for patients with Central Venous Access Devices (CVADs) as part

More information

PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0

PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0 PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0 Clinical Guideline Template Page 1 of 14 1. Aim/Purpose of this Guideline 1.1. This guideline

More information

TUBE FEEDING WITH NUTRICIA CHOICE

TUBE FEEDING WITH NUTRICIA CHOICE TUBE FEEDING WITH NUTRICIA CHOICE NURSE SUPPORT FLEXIBLE DELIVERIES OUT OF HOURS SUPPORT ENTERAL FEEDING PUMP SUPPORTING ALL YOUR TUBE FEEDING NEEDS EASY TO ORDER & PAY COMPREHENSIVE TUBE FEED PACKAGE

More information

STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.

STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION. STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION. Issue History Oct 12 Issue Version Two Purpose of Issue/Description of Change To ensure implementation

More information

Version: 4.0. Date Adopted: 21 November Name of Author: Patient Safety Group responsible Committee: Date issued for November 2017

Version: 4.0. Date Adopted: 21 November Name of Author: Patient Safety Group responsible Committee: Date issued for November 2017 Handover Policy This policy describes the process that staff should follow when handing over the care of patients in LPT including transfers to other care providers but excluding discharge. Key Words:

More information

Policy for the Administration of the First Dose of an Intravenous Antibiotic to Adult and Paediatric Patients by Nurses

Policy for the Administration of the First Dose of an Intravenous Antibiotic to Adult and Paediatric Patients by Nurses Policy for the Administration of the First Dose of an Intravenous Antibiotic to Adult and Paediatric Patients by Nurses September 2009 Policy Title: Policy for the Administration of the First Dose of an

More information

Injectable Medicines Policy. (Prescribing, Preparing and Administering Injectable Medicines Policy)

Injectable Medicines Policy. (Prescribing, Preparing and Administering Injectable Medicines Policy) Document Control Title Injectable Medicines Policy (Prescribing, Preparing and Administering Injectable Medicines Policy) Authors Directorate Trustwide Date Version Issued 0.1 May 2013 1.0 July 2013 1.1

More information

Facilitate arranging treatment around friends and family and organise social activities

Facilitate arranging treatment around friends and family and organise social activities Home Infusion Guide VPRIV (velaglucerase alfa for infusion) Gaucher disease, treatment and home infusion Together with your treating physician, you have decided to start home infusion therapy with VPRIV.

More information

Nottingham Neonatal Service Guidelines

Nottingham Neonatal Service Guidelines Title: Administration of Intravenous Medicines to Neonates Version: 11: V10 Sept 11; V9 Jan 2011; V8 June 2010; V7 Nov 2008; V6 Oct 2003; V5 March 2001; V4 May 1999; V3 Nov 1999; V2 1997; V1 1992 Ratification

More information

Administration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian

Administration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian Administration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian Lead Author/Coordinator: Jeff Horn / Sarah Howlett Macmillan Haematology CNS/ Pharmacist Reviewer: Gavin Preston Consultant Haematologist

More information

Infection Prevention and Control. Study guide

Infection Prevention and Control. Study guide Infection Prevention and Control Study guide Infection prevention and control Regulations CQC Outcome 8 Non Clinical Introduction All staff must be aware of the importance of Infection Prevention and Control

More information

You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath

You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath Nursing A guide for patients and carers Contents What is a TIVAD?... 1 Why is a TIVAD necessary?... 2 How a TIVAD is inserted...

More information

201 KAR 20:490. Licensed practical nurse intravenous therapy scope of practice.

201 KAR 20:490. Licensed practical nurse intravenous therapy scope of practice. 201 KAR 20:490. Licensed practical nurse intravenous therapy scope of practice. RELATES TO: KRS 314.011(10)(a), (c) STATUTORY AUTHORITY: KRS 314.011(10)(c), 314.131(1), 314.011(10)(c) NECESSITY, FUNCTION,

More information

Witnessing the Destruction of Stock Controlled Drugs within Wirral Community Trust Services

Witnessing the Destruction of Stock Controlled Drugs within Wirral Community Trust Services STANDARD OPERATING PROCEDURE Witnessing the Destruction of Stock Controlled Drugs within Wirral Community Trust Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One

More information